MedAlliance Swiss Medical Technology Employee Directory

Q: What is MedAlliance Swiss Medical Technology known for?

MedAlliance Swiss Medical Technology was founded in 2008. MedAlliance Swiss Medical Technology operates in the Medical Equipment Manufacturing industry.

Medical Equipment ManufacturingSwitzerland51-200 Employees

Founded in 2008, MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with offices in Germany, Singapore, UK, and USA.
MedAlliance specializes in the development of ground-breaking technology and commercialisation of advanced drug device combination products for the treatment of coronary and peripheral artery disease.

From the outset, MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threating diseases. Using breakthrough proprietary technology, MedAlliance has found a solution to the challenge of controlled and sustained sirolimus release with SELUTION SLR™, a drug-eluting balloon catheter with sustained limus release technology, for the treatment of both coronary and peripheral artery disease.

SELUTION SLR’s technology involves unique MicroReservoirs made from biodegradable polymer intermixed with the anti-restenotic drug sirolimus. These MicroReservoirs provide controlled and sustained release of the drug. Extended release of sirolimus from stents has been proven highly efficacious in both coronary and peripheral vasculatures. MedAlliance’s proprietary CAT™ (Cell Adherent Technology) enables the MicroReservoirs to be coated onto balloons and adhered to the vessel lumen when delivered via an angioplasty balloon.

In February 2019, MedAlliance became the first DEB company in the world to receive Breakthrough Device Designation Status for a coronary DEB from the US Food and Drug Administration (FDA). SELUTION SLR has now achieved this status for a range of indications: the treatment of AV-Fistula; coronary in-stent restenosis and peripheral below-the-knee lesions.

In February 2020 MedAlliance announced the award of its first CE Mark Approval: for SELUTION SLR in the treatment of peripheral arterial disease. In May 2020 the company announced the award of its second CE Mark: SELUTION SLR 014 PTCA for the treatment of coronary arterial disease.

Find MedAlliance Swiss Medical Technology employees' phone numbers or email addresses

MedAlliance Swiss Medical Technology Global Highlights

North America
37

United States Of America
37

Europe
14

Switzerland
8
United Kingdom Of Great Britain And Northern Ireland
2
Italy
1
Netherlands
1
Germany
1
France
1

Asia
2

India
2

MedAlliance Swiss Medical Technology's Leadership

A. W.
Sr Vice President Of Clinical And Regulatory At Medalliance
Mobile Phone
Email
S. M.
Senior Vp Global Clinical & Medical Affairs Coronary Interventions
Mobile Phone
Email
B. C. D. C.
Senior Director, Regulatory Affairs
Mobile Phone
Email
H. A.
Sr Director Clinical Operations
Mobile Phone
Email
T. C.
Director Of Analytical Chemistry
Mobile Phone
Email
E. M.
Product Director, Asia And Emerging Markets
Mobile Phone
Email
B. S.
Manager, Therapy Development
Mobile Phone
Email
C. M.
Sales And Marketing Manager
Mobile Phone
Email

Contact profiles from MedAlliance Swiss Medical Technology

Name

Title

Contact Info

Location

Last Update

C. W.
Manufacturing Manager
Mobile Phone
Email
SwitzerlandVaud
Oct 18, 2025
E. K.
Clinical Project Manager
Mobile Phone
Email
SwitzerlandVaud
Oct 08, 2024
M. C.
Marketing Consultant
Mobile Phone
Email
FranceNouvelle-Aquitaine
Nov 11, 2025
R. S.
Research & Development Chemitry Technician
Mobile Phone
Email
Oct 27, 2025
E. S.
Materials Management Analyst
Mobile Phone
Email
United States
Jul 14, 2025
A. Z.
Quality Assurance Technician
Mobile Phone
Email
Oct 16, 2024
S. O.
Research And Development Engineer
Mobile Phone
Email
Oct 16, 2024
V. P.
Manufacturing Technician
Mobile Phone
Email
United States
Oct 18, 2024

Frequently Asked Questions

What is MedAlliance Swiss Medical Technology known for?

MedAlliance Swiss Medical Technology was founded in 2008 operates in the Medical Equipment Manufacturing industry. The company's main headquarters is located in Rue de Rive 5, Nyon, Vaud 1260, CH. Explore MedAlliance Swiss Medical Technology's company overview page for more information.

What is MedAlliance Swiss Medical Technology's most common email format?

MedAlliance Swiss Medical Technology employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more MedAlliance Swiss Medical Technology email formats with LeadIQ.

How many employees does MedAlliance Swiss Medical Technology have currently?

MedAlliance Swiss Medical Technology has approximately 71 employees as of October 2025. These team members are located across 3 continents, including North AmericaEuropeAsia.

Who are MedAlliance Swiss Medical Technology's key employees and leadership?

As of October 2025, MedAlliance Swiss Medical Technology's key employees include:

Sr Vice President Of Clinical And Regulatory At Medalliance: A. W.
Senior Vp Global Clinical & Medical Affairs Coronary Interventions: S. M.
Senior Director, Regulatory Affairs: B. C. D. C.
Sr Director Clinical Operations: H. A.
Director Of Analytical Chemistry: T. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking